ERBB2 and large cell neuroendocrine carcinoma: According to a recent report from The Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM) (CLCGP-NGM 2013), a total of two (5 %) LCNEC tumors with ERBB2 amplification, but no SCLC tumors, have been reported, consistent with the present findings.